Qiagen N.V.
QGEN
Rangering i aksjer
#2134
Qiagen N.V. provides sample to insight solutions that transform biological... Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories. It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; oncology and sexual and reproductive health consumables, inclsuing assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. The company offers research PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID/forensics assay consumables comprising short tandem repeat assays for human ID, and assays for food contamination; PCR instruments, including digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It offers NGS gene panels, library prep kits and components, and whole genome amplification; DNA methylation analysis; QIAGEN consumables and instruments; bioinformatics solutions; and sequence-based assays forensic genetic genealog services. it provides software-as-a-service. It serves molecular diagnostics and life sciences sectors. The company was founded in 1984 and is headquartered in Venlo, the Netherlands.
Aksjekurs
$46.54
Sist synkronisert: 2026-10-19
Markedsverdi
$9.59B
Endring (1 dag)
0.79%
Endring (1 år)
-4.39%
Land
NL
Handel Qiagen N.V. (QGEN)
Kategori
Healthcare
EPS for Qiagen N.V. (QGEN)
EPS per June 2026 TTM: $1.95
Ifølge de siste økonomiske rapportene og aksjekursen til Qiagen N.V. er selskapets nåværende EPS (TTM) $1.95. Ved slutten av 2024 hadde selskapet en EPS på $0.39, en nedgang sammenlignet med EPS-en i 2023 som var $1.67.
EPS-historikk for Qiagen N.V. fra 2000 til 2026
EPS ved slutten av hvert år
| År | EPS | Endre |
|---|---|---|
| 2026 (TTM) | $1.95 | -4.41% |
| 2025 | $2.04 | 423.08% |
| 2024 | $0.39 | -76.65% |
| 2023 | $1.67 | -19.71% |
| 2022 | $2.08 | -17.46% |
| 2021 | $2.52 | 663.64% |
| 2020 | $0.33 | -273.68% |
| 2019 | $-0.19 | -122.62% |
| 2018 | $0.84 | 366.67% |
| 2017 | $0.18 | -50.00% |
| 2016 | $0.36 | -36.84% |
| 2015 | $0.57 | 9.62% |
| 2014 | $0.52 | 67.74% |
| 2013 | $0.31 | -45.61% |
| 2012 | $0.57 | 32.56% |
| 2011 | $0.43 | -32.81% |
| 2010 | $0.64 | -8.57% |
| 2009 | $0.70 | 48.94% |
| 2008 | $0.47 | 51.61% |
| 2007 | $0.31 | -36.73% |
| 2006 | $0.49 | 11.36% |
| 2005 | $0.44 | 29.41% |
| 2004 | $0.34 | 13.33% |
| 2003 | $0.30 | 76.47% |
| 2002 | $0.17 | -32.00% |
| 2001 | $0.25 | 56.25% |
| 2000 | $0.16 | 0.00% |
EPS for lignende selskaper eller konkurrenter
| Selskap | EPS | EPS-forskjell | Land |
|---|---|---|---|
| $18.62 | 854.87% |
US
|
|
| $5.65 | 189.74% |
US
|
|
| $-1.36 | -169.74% |
US
|
|
| - | - |
CN
|
|
| $5.09 | 161.03% |
US
|
